Wells Fargo & Company »

Telomir Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.6k 1.8k 4.81

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth Call Option (UNH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wells Fargo & Company

Top funds holding Telomir Pharmaceuticals

BlackRock
Geode Capital Management
Suncoast Equity Management
Bank of New York Mellon
Vanguard Group
State Street Corporation
Beaird Harris Wealth Management
New York State Common Retirement Fund
Charles Schwab Investment Management
Citigroup
Morgan Stanley
Rhumbline Advisers
Bank of America Corporation
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Telomir Pharmaceuticals